PMC:7796041 / 16655-16757
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"456","span":{"begin":69,"end":77},"obj":"Species"},{"id":"459","span":{"begin":19,"end":37},"obj":"Chemical"}],"attributes":[{"id":"A456","pred":"tao:has_database_id","subj":"456","obj":"Tax:9606"},{"id":"A459","pred":"tao:has_database_id","subj":"459","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In both subgroups, hydroxychloroquine was used in 44.1% and 44.6% of patients, respectively (Table 1)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T148","span":{"begin":0,"end":102},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In both subgroups, hydroxychloroquine was used in 44.1% and 44.6% of patients, respectively (Table 1)."}